Evonik to buy CDMO for drug delivery technologies

By Staff Reporter

- Last updated on GMT

iStock/Carther
iStock/Carther

Related tags Drug delivery Health care Pharmacology

Evonik has bought Transferra Nanosciences to expand its injectable drug delivery technology offering.

The acquisition – terms of which have not been disclosed – is expected to close at the end of the month.

Burnaby, Canada-based Transferra – previously known as Northern Lipids – has a portfolio of liposomal drug delivery systems. The firm also provides process development, analytical support services and the production of clinical trial materials.

Reiner Beste, chairman of the board of Evonik Nutrition & Care GmbH, said: “This transaction reflects our continued commitment to growth in the health care area and in the drug delivery space in particular​.”

This was echoed by Jean-Luc Herbeaux, head of the Health Care Business Line at Evonik.

The combination of the drug delivery businesses of Transferra and Evonik will form a leading service provider providing a full array of services, ranging from prototype identification to commercial manufacturing​.”

Evonik’s last delivery technology focused agreement was in 2011​ when it acquired the assets of SurModics in a deal that also saw it buy the latter’s manufacturing facility in Birmingham, Alabama.

Related news

Show more

Related products

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Product Brochure

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us

Products

View more

Webinars